Scale up period | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|---|---|---|---|---|
Anxiety disorders | |||||||||||
Basic psychosocial treatment and anti-depressant medication for anxiety disorders | 40 | 43.9 | 47.5 | 50.9 | 54.1 | 57.1 | 59.9 | 62.6 | 65.2 | 67.7 | 70 |
Intensive psychosocial treatment and medication therapy for anxiety disorders | 1 | 12.6 | 17.3 | 20.4 | 22.6 | 24.4 | 25.8 | 27.1 | 28.2 | 29.1 | 30 |
Depression | |||||||||||
Basic psychosocial treatment and anti-depressant medication of first episode cases | 40 | 43.0 | 46.0 | 49.0 | 52.0 | 55.0 | 58.0 | 61.0 | 64.0 | 67.0 | 70 |
Intensive psychosocial treatment and anti-depressant medication of first episode cases | 1 | 3.9 | 6.8 | 9.7 | 12.6 | 15.5 | 18.4 | 21.3 | 24.2 | 27.1 | 30 |
Intensive psychosocial treatment and anti-depressant medication of moderate-severe cases on a maintenance basis | 1 | 3.9 | 6.8 | 9.7 | 12.6 | 15.5 | 18.4 | 21.3 | 24.2 | 27.1 | 30 |
Bipolar disorder | |||||||||||
Intensive psychosocial intervention for bipolar disorder, plus mood-stabilizing medication | 1 | 12.6 | 17.3 | 20.4 | 22.6 | 24.4 | 25.8 | 27.1 | 28.2 | 29.1 | 30 |
Epilepsy | |||||||||||
Basic psychosocial support, advice, and follow-up, plus anti-epileptic medication | 40 | 43.9 | 47.5 | 50.9 | 54.1 | 57.1 | 59.9 | 62.6 | 65.2 | 67.7 | 70 |